Arab Finance: The Egyptian International Pharmaceutical Industries Company (EIPICO) has denied receiving any offers to sell the main shareholder’s stake in the company to a strategic investor, according to a filing sent to the Egyptian Exchange (EGX) on August 29th.
The disclosure came as a response to the circulated rumors regarding this matter.
EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry.